BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23010175)

  • 1. PEP-1-p18 prevents neuronal cell death by inhibiting oxidative stress and Bax expression.
    Kim DS; Sohn EJ; Kim DW; Kim YN; Eom SA; Yoon GH; Cho SW; Lee SH; Hwang HS; Cho YS; Park J; Eum WS; Choi SY
    BMB Rep; 2012 Sep; 45(9):532-7. PubMed ID: 23010175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEP-1-heat shock protein 27 protects from neuronal damage in cells and in a Parkinson's disease mouse model.
    Lee YP; Kim DW; Kang HW; Hwang JH; Jeong HJ; Sohn EJ; Kim MJ; Ahn EH; Shin MJ; Kim DS; Kang TC; Kwon OS; Cho SW; Park J; Eum WS; Choi SY
    FEBS J; 2012 Jun; 279(11):1929-42. PubMed ID: 22429328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson's Disease.
    Choi YJ; Kim DW; Shin MJ; Yeo HJ; Yeo EJ; Lee LR; Song Y; Kim DS; Han KH; Park J; Lee KW; Park JK; Eum WS; Choi SY
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34206041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEP-1-PEA-15 protects against toxin-induced neuronal damage in a mouse model of Parkinson's disease.
    Ahn EH; Kim DW; Shin MJ; Kim HR; Kim SM; Woo SJ; Eom SA; Jo HS; Kim DS; Cho SW; Park J; Eum WS; Choi SY
    Biochim Biophys Acta; 2014 Jun; 1840(6):1686-700. PubMed ID: 24412329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEP-1-ribosomal protein S3 protects dopaminergic neurons in an MPTP-induced Parkinson's disease mouse model.
    Ahn EH; Kim DW; Shin MJ; Kim YN; Kim HR; Woo SJ; Kim SM; Kim DS; Kim J; Park J; Eum WS; Hwang HS; Choi SY
    Free Radic Biol Med; 2013 Feb; 55():36-45. PubMed ID: 23178948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transduced PEP-1-PON1 proteins regulate microglial activation and dopaminergic neuronal death in a Parkinson's disease model.
    Kim MJ; Park M; Kim DW; Shin MJ; Son O; Jo HS; Yeo HJ; Cho SB; Park JH; Lee CH; Kim DS; Kwon OS; Kim J; Han KH; Park J; Eum WS; Choi SY
    Biomaterials; 2015 Sep; 64():45-56. PubMed ID: 26117230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of PEP-1-Catalase on stress-induced cellular toxicity and MPTP-induced Parkinson's disease.
    Eom SA; Kim DW; Shin MJ; Ahn EH; Chung SY; Sohn EJ; Jo HS; Jeon SJ; Kim DS; Kwon HY; Cho SW; Han KH; Park J; Eum WS; Choi SY
    BMB Rep; 2015 Jul; 48(7):395-400. PubMed ID: 25322954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEP-1-HO-1 prevents MPTP-induced degeneration of dopaminergic neurons in a Parkinson's disease mouse model.
    Youn JK; Kim DW; Kim ST; Park SY; Yeo EJ; Choi YJ; Lee HR; Kim DS; Cho SW; Han KH; Park J; Eum WS; Hwang HS; Choi SY
    BMB Rep; 2014 Oct; 47(10):569-74. PubMed ID: 24499676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
    Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
    Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEP-1-metallothionein-III protein ameliorates the oxidative stress-induced neuronal cell death and brain ischemic insults.
    Sohn EJ; Kim DW; Kim MJ; Jeong HJ; Shin MJ; Ahn EH; Kwon SW; Kim YN; Kim DS; Han KH; Park J; Hwang HS; Eum WS; Choi SY
    Biochim Biophys Acta; 2012 Oct; 1820(10):1647-55. PubMed ID: 22743691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice.
    Guo C; Hao LJ; Yang ZH; Chai R; Zhang S; Gu Y; Gao HL; Zhong ML; Wang T; Li JY; Wang ZY
    Exp Neurol; 2016 Jun; 280():13-23. PubMed ID: 26996132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
    Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
    J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease.
    Kim M; Cho KH; Shin MS; Lee JM; Cho HS; Kim CJ; Shin DH; Yang HJ
    Int J Mol Med; 2014 Apr; 33(4):870-8. PubMed ID: 24535622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selenoprotein T Exerts an Essential Oxidoreductase Activity That Protects Dopaminergic Neurons in Mouse Models of Parkinson's Disease.
    Boukhzar L; Hamieh A; Cartier D; Tanguy Y; Alsharif I; Castex M; Arabo A; El Hajji S; Bonnet JJ; Errami M; Falluel-Morel A; Chagraoui A; Lihrmann I; Anouar Y
    Antioxid Redox Signal; 2016 Apr; 24(11):557-74. PubMed ID: 26866473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
    J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEP-1-GSTpi protein enhanced hippocampal neuronal cell survival after oxidative damage.
    Sohn EJ; Shin MJ; Kim DW; Son O; Jo HS; Cho SB; Park JH; Lee CH; Yeo EJ; Choi YJ; Yu YH; Kim DS; Cho SW; Kwon OS; Cho YJ; Park J; Eum WS; Choi SY
    BMB Rep; 2016 Jul; 49(7):382-7. PubMed ID: 27049109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of transduced PEP-1-Frataxin protein on oxidative stress-induced neuronal cell death.
    Kim MJ; Kim DW; Yoo KY; Sohn EJ; Jeong HJ; Kang HW; Shin MJ; Ahn EH; An JJ; Kwon SW; Kim YN; Won MH; Cho SW; Park J; Eum WS; Choi SY
    J Neurol Sci; 2010 Nov; 298(1-2):64-9. PubMed ID: 20817181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Damage to dopaminergic neurons is mediated by proliferating cell nuclear antigen through the p53 pathway under conditions of oxidative stress in a cell model of Parkinson's disease.
    Li DW; Li GR; Zhang BL; Feng JJ; Zhao H
    Int J Mol Med; 2016 Feb; 37(2):429-35. PubMed ID: 26677001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of Tat-ATOX1 protein against MPP
    Eum WS; Shin MJ; Lee CH; Yeo HJ; Yeo EJ; Choi YJ; Kwon HJ; Kim DS; Kwon OS; Lee KW; Han KH; Park J; Kim DW; Choi SY
    Biochimie; 2019 Jan; 156():158-168. PubMed ID: 30352250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.